Alpha Teknova (TKNO) Total Non-Current Liabilities (2020 - 2025)
Alpha Teknova (TKNO) reported Total Non-Current Liabilities of $34.8 million for Q4 2025, down 3.31% year-over-year from $36.0 million in Q4 2024, and little changed quarter-over-quarter from $35.0 million in Q3 2025.
Alpha Teknova (TKNO) Total Non-Current Liabilities (2020 - 2025) Analysis & Trends
Alpha Teknova (TKNO) has 6 years of Total Non-Current Liabilities data on file, last reported at $34.8 million in Q4 2025.
- Total Non-Current Liabilities for Q4 2025 came in at $34.8 million, down 3.31% year-over-year; the trailing twelve-month figure through Dec 2025 was $34.8 million (down 3.31% YoY), and the FY2025 annual result was $34.8 million, down 3.31% from the prior year.
- Total Non-Current Liabilities steadied at $34.8 million in Q4 2025 per TKNO's latest filing, from $35.0 million in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $52.2 million in Q4 2022 and troughed at $22.6 million in Q3 2021.
- A 5-year average of $37.9 million and a median of $36.8 million in 2024 frame the typical range for Total Non-Current Liabilities.
- The sharpest annual moves came in 2021 and 2023: Total Non-Current Liabilities jumped 126.81% in 2021, then declined 26.7% in 2023.
- A 5-year view of Total Non-Current Liabilities shows it stood at $23.0 million in 2021, then surged by 126.55% to $52.2 million in 2022, then declined by 26.7% to $38.3 million in 2023, then declined by 5.88% to $36.0 million in 2024, then declined by 3.31% to $34.8 million in 2025.
- Business Quant data shows TKNO's Total Non-Current Liabilities at $34.8 million in Q4 2025, $35.0 million in Q3 2025, and $34.4 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 18.28 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 11.64 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 599.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 44.12 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 1.24 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 6.26 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 2.44 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.13 Bn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 1.81 Bn |
| 10 | Alpha Teknova | 249.27 Mn | 231.49 Mn | 3.78 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 34.81 Mn |
| Sep 30, 2025 | 34.98 Mn |
| Jun 30, 2025 | 34.43 Mn |
| Mar 31, 2025 | 35.02 Mn |
| Dec 31, 2024 | 36.00 Mn |
| Sep 30, 2024 | 36.80 Mn |
| Jun 30, 2024 | 36.05 Mn |
| Mar 31, 2024 | 37.36 Mn |
| Dec 31, 2023 | 38.25 Mn |
| Sep 30, 2023 | 38.61 Mn |
| Jun 30, 2023 | 46.19 Mn |
| Mar 31, 2023 | 48.77 Mn |
| Dec 31, 2022 | 52.19 Mn |
| Sep 30, 2022 | 48.06 Mn |
| Jun 30, 2022 | 48.50 Mn |
| Mar 31, 2022 | 45.28 Mn |
| Dec 31, 2021 | 23.04 Mn |
| Sep 30, 2021 | 22.64 Mn |
| Jun 30, 2021 | 23.22 Mn |
| Dec 31, 2020 | 10.16 Mn |